At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 50 target
Drug / intervention
splenectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NCT03998059N/ARecruitingUpdate OverdueUpdated 16mo ago · Completion was 53mo agoEnrollment Stalled
Long Recruiting
Update Overdue
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
Institute of Hematology & Blood Diseases Hospital, China·observational·Posted Jun 25, 2019·Updated Feb 24, 2025
In Brief
An observational study evaluating splenectomy for Thrombocytopenia and Splenectomy. Currently recruiting, targeting 50 participants across 1 site.
Signals
Enrollment appears stalled
Detailed Summary
Evaluation of immune status before and after splenectomy in immune thrombocytopenia patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsThrombocytopenia, Splenectomy
CountriesChina
Collaborators--
Timeline
N/ARecruitingOverdue
20192020202120222023202420252026
Enrollment StartJan 2019
First PostedJun 2019
Primary CompletionJan 2022
Study CompletionJul 2025
TodayJul 2026
First PostedJun 25, 2019
Enrollment StartJan 23, 2019
Primary CompletionJan 23, 2022
Study CompletionJul 23, 2025
TodayJul 1, 2026
Enrollment to primary: 3 yearsPosted 7.0 years ago
Interventions
splenectomyprocedure
These patients should fail to have sustained response to multiple first- and second-line treatments of ITP and agree to have splenectomy.Before splenectomy, these patients will be reassessed and still diagnosed with ITP.Their platelet level will be raised to a safe state before surgery, and the laparoscopic splenectomy will be performed in Tianjin People's Hospital.